Albemarle traded at $174.50 this Thursday March 26th, decreasing $6.89 or 3.80 percent since the previous trading session. Looking back, over the last four weeks, Albemarle lost 2.33 percent. Over the last 12 months, its price rose by 133.44 percent. Looking ahead, we forecast Albemarle to be priced at 175.95 by the end of this quarter and at 160.58 in one year, according to Trading Economics global macro models projections and analysts expectations.
Albemarle Corporation is a global developer, manufacturer and marketer of highly-engineered specialty chemicals. The Company operates through three segments: Lithium, Bromine Specialties and Catalysts. The Lithium segment develops lithium-based materials for a wide range of industries and end markets. It develops and manufactures a broad range of basic lithium compounds, including lithium carbonate, lithium hydroxide, lithium chloride, and value-added lithium specialties and reagents. The Company's Bromine Specialties segment is focused on bromine and bromine-based business, which includes products used in fire safety solutions and other specialty chemicals applications. The Catalysts segment consists of three main product lines: Clean Fuels Technologies, which is primarily composed of hydroprocessing catalysts (HPC) together with isomerization and akylation catalysts; fluidized catalytic cracking (FCC) catalysts and additives; and performance catalyst solutions (PCS).